Pioglitazone
Pre-clinicalCompleted 0 watching 0 views this week๐ค Quiet
20
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Peritoneal Dialysis
Conditions
Peritoneal Dialysis, Pioglitazone, Hypertriglyceridemia, Insulin Resistance, Inflammation
Trial Timeline
Jan 1, 2008 โ Sep 1, 2008
NCT ID
NCT01258322About Pioglitazone
Pioglitazone is a pre-clinical stage product being developed by Baxter for Peritoneal Dialysis. The current trial status is completed. This product is registered under clinical trial identifier NCT01258322. Target conditions include Peritoneal Dialysis, Pioglitazone, Hypertriglyceridemia.
Hype Score Breakdown
Clinical
5
Activity
2
Company
7
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01258322 | Pre-clinical | Completed |
Competing Products
20 competing products in Peritoneal Dialysis